Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer

Annals of Surgical Oncology

Volumn 24, Issue 7, 2017, Pages 1804-1810

  Kudou, Kensuke ^a   Saeki, Hiroshi ^a   Nakashima, Yuichiro ^a   Edahiro, Keitaro ^a   Korehisa, Shotaro ^a   Taniguchi, Daisuke ^a   Tsutsumi, Ryosuke ^a   Nishimura, Sho ^a   Nakaji, Yu ^a   Akiyama, Shingo ^a   Tajiri, Hirotada ^a   Nakanishi, Ryota ^a   Kurashige, Junji ^a   Sugiyama, Masahiko ^a   Oki, Eiji ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOGRAPHY; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGOGASTRIC JUNCTION CANCER; ESOPHAGUS CANCER; FEMALE; GASTROESOPHAGEAL JUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; RECURRENCE FREE SURVIVAL; SARCOPENIA; SKELETAL MUSCLE; STOMACH CANCER; SURVIVAL RATE; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC IMAGING; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FOLLOW UP; GASTRECTOMY; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH TUMOR; X-RAY COMPUTED TOMOGRAPHY;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MUSCLE, SKELETAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; STOMACH NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85013500100     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-017-5811-9     Document Type: Article

References (30)

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S–91S.
2. Von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle. 2010;1:129–33.
3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39:412–23.
4. Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523–30.
5. Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.
6. Go SI, Park MJ, Song HN, et al. Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support Care Cancer. 2016;24:2075–84.
7. Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015;22:2663–8.
8. Choi Y, Oh DY, Kim TY, et al. Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS ONE. 2015;10:e0139749.
9. Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2011;62:265–79.
10. Tamandl D, Paireder M, Asari R, et al. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol. 2016;26:1359–67.
11. Tegels JJ, van Vugt JL, Reisinger KW, et al. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol. 2015;112:403–7.
12. Liu K, Zhang W, Chen X, et al. Comparison on clinicopathological features and prognosis between esophagogastric junctional adenocarcinoma (Siewert II/III types) and distal gastric adenocarcinoma: retrospective cohort study, a single-institution, high-volume experience in China. Medicine. 2015;94:e1386.
13. Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction—classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82.
14. Yoshizumi T, Shirabe K, Nakagawara H, et al. Skeletal muscle area correlates with body surface area in healthy adults. Hepatol Res. 2014;44:313–8.
15. Matsubara Y, Matsumoto T, Aoyagi Y, et al. Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg. 2015;61:945–50.
16. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47.
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
18. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.
19. Mizuno A, Kanda M, Kobayashi D, et al. Adverse effects of intraoperative blood loss on long-term outcomes after curative gastrectomy of patients with stage II/III gastric cancer. Dig Surg. 2016;33:121–8.
20. Liang YX, Guo HH, Deng JY, et al. Impact of intraoperative blood loss on survival after curative resection for gastric cancer. World J Gastroenterol. 2013;19:5542–50.
21. Nakamura H, Saji H, Kurimoto N, et al. Impact of intraoperative blood loss on long-term survival after lung cancer resection. Ann Thorac Cardiovasc Surg. 2015;21:18–23.
22. Jiang W, Fang YJ, Wu XJ, et al. Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis. PLoS ONE. 2013;8:e76125.
23. Margonis GA, Kim Y, Samaha M, et al. Blood loss and outcomes after resection of colorectal liver metastases. J Surg Res. 2016;202:473–80.
24. Suetta C, Magnusson SP, Beyer N, et al. Effect of strength training on muscle function in elderly hospitalized patients. Scand J Med Sci Sports. 2007;17:464–72.
25. Fukuda Y, Yamamoto K, Hirao M, et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2016;19:986–93.
26. Joglekar S, Asghar A, Mott SL, et al. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol. 2015;111:771–5.
27. Peng PD, van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB Oxford. 2011;13:439–46.
28. Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2015;261:345–52.
29. Braghetto MI, Cardemil HG, Mandiola BC, et al. Impact of minimally invasive surgery in the treatment of esophageal cancer. Arq Bras Cir Dig. 2014;27:237–42.
30. Yoshida N, Baba Y, Watanabe M, et al. Original scoring system for predicting postoperative morbidity after esophagectomy for esophageal cancer. Surg Today. 2015;45:346–54.